Drugs / Neoadjuvant Epigenetic Therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06888102 | Apr 2026 → Oct 2028 expected | prostate cancer | Edwin Posadas, MD | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neoadjuvant Epigenetic Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06888102 ↗ |